Related Experiment Video
Updated: Oct 30, 2025
05:04
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
1.2K
Development of innovative simulation teaching for advanced general practice clinical pharmacists
G F Rushworth1,2, C Innes3,4, A Macdonald5
1Highland Pharmacy Education & Research Centre (HPERC), NHS Highland, Centre for Health Science, Inverness, IV2 3JH, UK. gordon.rushworth@nhs.scot.
International Journal of Clinical Pharmacy
|July 2, 2021
Summary
Simulation training enhanced confidence and competence for Advanced General Practice Clinical Pharmacists (GPCPs) in managing diverse patient scenarios. This innovative approach is recommended for postgraduate pharmacist development.
Area of Science:
- Pharmacy Education
- Clinical Skills Simulation
- General Practice Pharmacy
Background:
- Advanced General Practice Clinical Pharmacists (GPCPs) require autonomous decision-making skills for patient management.
- Simulation offers a safe environment for clinical skill development but is underutilized in postgraduate pharmacy education.
Purpose of the Study:
- To design and implement innovative simulation teaching for Advanced GPCPs in Scotland.
- To enhance the clinical assessment and decision-making capabilities of GPCPs.
Main Methods:
- A simulation day was developed with ten general practice clinical scenarios.
- Learning objectives aligned with the National Advanced GPCP competency framework.
- Immersive simulation sessions included mannequin use and provided immediate verbal and written feedback.
Main Results:
- Participants reported increased confidence and competence in consultation and clinical skills.
- Qualitative feedback highlighted the value of real-time feedback in building confidence.
- The simulation effectively addressed typical general practice scenarios.
Conclusions:
- Innovative simulation training is valuable for GPCPs, enhancing confidence and competence in general practice settings.
- A Scottish Pharmacy Simulation Faculty is proposed to support ongoing training across health boards.
Related Concept Videos
01:28Preclinical Development: Overview
5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
01:26Drug Administration and Therapy Phases: Overview
911
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
911
01:24Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
1.7K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
1.7K
01:12Analysis of Population Pharmacokinetic Data
479
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
479
01:20Pharmacokinetic Models: Overview
1.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.4K
01:19Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K